Dr. Shi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2505 W Hammer Ln
Stockton, CA 95209Phone+1 209-957-7050- Is this information wrong?
Education & Training
Valley Baptist Medical CenterResidency, Family Medicine, 2000 - 2003- OtherClass of 1985
Certifications & Licensure
CA State Medical License 2002 - 2024
TX State Medical License 2003 - 2007- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 63 citationsActivity of the Fibroblast Growth Factor Receptor Inhibitors Dovitinib (TKI258) and NVP-BGJ398 in Human Endometrial Cancer CellsGottfried E. Konecny, Teodora Kolarova, Neil A. O'Brien, Boris Winterhoff, Guorong Yang, Jingwei Qi, Zhengdong Qi, Natarajan Venkatesan, Raul Ayala, Tong Luo, Richard ...> ;Molecular Cancer Therapeutics. 2013 May 1
- 2 citationsThe USCACA hosted symposiums at the 7th CACA annual meeting and the 15th CSCO annual meeting in Beijing.Michael Shi, Wancai Yang, Pascal Qian, Li Yan> ;Chinese Journal of Cancer. 2012 Nov 1
Press Mentions
Transcenta Releases Phase I Clinical Data of TST001 in Combination with CAPOX as the First Line Treatment of Advanced and Metastatic G/GEJ Cancer at ASCO 2022June 2nd, 2022- Transcenta Doses First Subject in Phase I Osteoporosis Drug Trial in ChinaApril 29th, 2022
- More Unique Therapeutic Possibilities Posed by Rare Human GenesMarch 14th, 2022
- Join now to see all
Hospital Affiliations
Memorial Medical CenterModesto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
